The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
How Long Does Mounjaro Nausea Last?
Nausea is one of the most common side effects when starting Mounjaro (tirzepatide), affecting more than 1 in 10 people. The duration and severity vary significantly between individuals—some experience mild nausea that settles within days, while others notice it persists for weeks, particularly during dose increases. Understanding what to expect and how it compares to other GLP-1 medications like Wegovy can help you make an informed decision. This guide explains the timeline, what the clinical evidence shows, and practical tips for managing nausea whilst your body adjusts.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
Mounjaro vs Wegovy: Nausea Timeline and Mechanism
Both Mounjaro and Wegovy cause nausea through similar mechanisms—they slow how quickly food leaves your stomach and signal fullness to your brain—but the pattern and duration can differ. Mounjaro is a dual GIP and GLP-1 receptor agonist, whilst Wegovy activates GLP-1 only, which may influence how your digestive system responds.
Mounjaro nausea typically:
- Starts within the first few days of injection or dose increase
- Peaks around days 3–5 after injection
- Often improves by week 2–3 on the same dose
- May return or worsen when you increase to the next dose (every 4 weeks)
- Generally settles after staying on the same dose for several weeks
Wegovy nausea follows a similar pattern but some prescribers report slightly less severe nausea in early weeks, though individual variation is significant. Clinical trial data from SURMOUNT-1 (Mounjaro) and STEP-1 (Wegovy) show nausea affects 25–40% of participants, with most experiencing mild to moderate symptoms that improve with time and dose stabilisation.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Duration Varies by Individual and Dose Escalation
There is no fixed timeline—nausea can last from a few days to several weeks depending on your body's adjustment, what you eat, and your dose schedule. Most people report significant improvement after 2–4 weeks on the same dose, but each dose increase may trigger nausea again, albeit often less severely than the initial injection.
If nausea persists beyond 4 weeks on the same dose, or is severe enough to affect eating and hydration, contact your GP or prescriber. They may recommend staying on your current dose longer before increasing, adjusting your eating pattern, or trying anti-nausea strategies. Your prescriber can also assess whether the medication remains appropriate for you or whether switching to an alternative GLP-1 option like Wegovy might suit you better. Use our GLP-1 weight loss calculator to explore potential outcomes at different doses, and our BMI calculator to monitor your baseline health metrics alongside any medication decision.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Does Mounjaro nausea last longer than Wegovy nausea?
Not necessarily. Clinical trials show both cause nausea in roughly similar percentages. Duration depends more on individual tolerance, dose escalation speed, and how you manage side effects (eating small, frequent meals, staying hydrated) than on the medication type itself. Your prescriber can adjust your pace if nausea is severe.
Is nausea worse when you increase your Mounjaro dose?
Often yes. Each dose increase from 2.5mg up to 15mg may trigger nausea again, though it typically settles faster than after your first injection. Many people find the second and third dose increases cause less nausea than the first. Staying on the same dose for longer can help your body adjust before escalating.
What can I do to reduce Mounjaro nausea?
Eat small, frequent meals rather than large ones. Avoid fatty, greasy, or strongly flavoured foods. Stay well-hydrated with water and electrolyte drinks. Ginger tea or peppermint may help some people. Avoid sudden position changes. If nausea is severe, your prescriber may recommend anti-nausea medication or delaying your next dose increase.
If Mounjaro nausea is too severe, can I switch to Wegovy?
Possibly, but only with prescriber guidance. Switching medications is a clinical decision based on your full health picture. Some people tolerate Wegovy better, whilst others find nausea similar. Your prescriber will assess whether the switch is appropriate and manage the transition safely.
When should I contact my GP about Mounjaro nausea?
Contact your GP if nausea is so severe you cannot eat or drink, lasts beyond 4–5 weeks on the same dose, or is affecting your quality of life significantly. Also seek advice if you experience vomiting (different from nausea), dizziness, or signs of dehydration. Your prescriber can help adjust your plan.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.